11β-hydroxysteroid dehydrogenase type 1, brain atrophy and cognitive decline

Neurobiology of Aging

Volumn 33, Issue 1, 2012, Pages 207.e1-207.e8

  MacLullich, Alasdair M J ^a,b   Ferguson, Karen J ^b   Reid, Louise M ^b   Deary, Ian J ^b   Starr, John M ^b   Wardlaw, Joanna M ^b,c   Walker, Brian R ^a   Andrew, Ruth ^a   Seckl, Jonathan R ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Scottish Imaging Network   (United Kingdom)

Author keywords

Aging; Cerebral atrophy; Cognition; Cortisol; Dementia; Glucocorticoids; White matter lesions

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 5ALPHA TETRAHYDROCORTISOL; 5BETA TETRAHYDROCORTISOL; HYDROCORTISONE; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE; UNCLASSIFIED DRUG;

AGED; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; HUMAN; IMAGE ANALYSIS; INFORMATION PROCESSING; LONGITUDINAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; URINALYSIS; VOLUNTEER; WHITE MATTER;

EID: 81355141953     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.09.010     Document Type: Article

References (50)

1. Andrew R., Phillips D.I.W., Walker B.R. Obesity and gender influence cortisol secretion and metabolism in man. J. Clin. Endocrinol. Metab 1998, 83:1806-1809.
2. Andrew R., Westerbacka J., Wahren J., Yki-Jarvinen H., Walker B.R. The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans. Diabetes 2005, 54:1364-1370.
3. Armanini M.P., Hutchins C., Stein B.A., Sapolsky R.M. Glucocorticoid Endangerment of Hippocampal-Neurons Is NMDA-Receptor Dependent. Brain Res 1990, 532:7-12.
4. Basu R., Singh R.J., Basu A., Chittilapilly E.G., Johnson C.M., Toffolo G., Cobelli C., Rizza R.A. Splanchnic cortisol production occurs in humans - Evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11 beta-HSD) type 1 pathway. Diabetes 2004, 53:2051-2059.
5. Best R., Walker B.R. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo. Clin. Endocrinol 1997, 47:231-236.
6. Carlson N.E., Moore M.M., Dame A., Howieson D., Silbert L.C., Quinn J.F., Kaye J.A. Trajectories of brain loss in aging and the development of cognitive impairment. Neurology 2008, 70:828-833.
7. Carmichael O.T., Kuller L.H., Lopez O.L., Thompson P.M., Dutton R.A., Lu A., Lee S.E., Lee J.Y., Aizenstein H.J., Meltzer C.C., Liu Y.X., Toga A.W., Becker J.T. Ventricular volume and dementia progression in the Cardiovascular Health Study. Neurobiol. Aging 2007, 28:389-397.
8. Catania C., Sotirpoulos I., Silva R., Onofri C., Breen K.C., Sousa N., Almeida O.F. The amyloidogenic potential and behavioral correlates of stress. Mol. Psychiatry 2009, 14:95-105.
9. Courtney R., Stewart P.M., Toh M., Ndongo M.N., Calle R.A., Hirshberg B. Modulation of 11 beta-hydroxysteroid dehydrogenase (11 beta HSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11 beta HSD1 inhibitor. J. Clin. Endocrinol. Metab 2008, 93:550-556.
10. de Kloet E.R. Hormones and the stressed brain. Stress Curr. Neuroendocrine Genet. Approaches 2004, 1018:1-15.
11. Elgh E., Astot A.L., Fagerlund M., Eriksson S., Olsson T., Nasman B. Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease. Biol. Psychiatry 2006, 59:155-161.
12. Fazekas F., Kleinert R., Offenbacher H., Schmidt R., Kleinert G., Payer F., Radner H., Lechner H. Pathological Correlates of Incidental MRI White-Matter Signal Hyperintensities. Neurology 1993, 43:1683-1689.
13. Ferguson K.J., Wardlaw J.M., MacLullich A.M.J. Quantitative and qualitative measures of hippocampal atrophy are not correlated in healthy older men. J. Neuroimaging 2010, 20:157-162.
14. Ferguson K.J., Wardlaw J.M., Edmond C.L., Deary I.J., MacLullich A.M.J. Intracranial area: A validated method for estimating intracranial volume. J. Neuroimaging 2005, 15:76-78.
15. Finkel D., McArdle J.J., Reynolds C.A., Pedersen N.L. Age changes in processing speed as a leading indicator of cognitive aging. Psych. Aging 2007, 22:558-568.
16. Holmes M.C., Carter R.N., Noble J., Chitnis S., Dutia A., Paterson J.M., Mullins J.J., Seckl J.R., Yau J.L.W. 11 beta-Hydroxysteroid Dehydrogenase Type 1 Expression Is Increased in the Aged Mouse Hippocampus and Parietal Cortex and Causes Memory Impairments. J. Neurosci 2010, 30:6916-6920.
17. Holmes M.C., Seckl J.R. The role of 11 beta-hydroxysteroid dehydrogenases in the brain. Mol. Cell. Endocrinol 2006, 248:9-14.
18. Issa A.M., Rowe W., Gauthier S., Meaney M.J. Hypothalamic-Pituitary-Adrenal Activity in Aged, Cognitively Impaired and Cognitively Unimpaired Rats. J. Neurosci 1990, 10:3247-3254.
19. Karlamangla A.S., Singer B.H., Chodosh J., McEwen B.S., Seeman T.E. Urinary cortisol excretion as a predictor of incident cognitive impairment. Neurobiol. Aging 2005, 26:S80-S84.
20. Lee K.W., Kim J.B., Seo J.S., Kim T.K., Im J.Y., Baek I.S., Kim K.S., Lee J.K., Han P.L. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress. J. Neurochem 2009, 108:165-175.
21. Lezak M. Neuropsychological Assessment 1995, Oxford University Press, Oxford. 3rd Ed.
22. Longstreth W.T., Arnold A.M., Manolio T.A., Burke G.L., Bryan N., Jungreis C.A., O'Leary D., Enright P.L., Fried L. Clinical correlates of ventricular and sulcal size on cranial magnetic resonance imaging of 3,301 elderly people - The cardiovascular health study. Neuroepidemiology 2000, 19:30-42.
23. Low S.C., Moisan M.P., Noble J.M., Edwards C.R.W., Seckl J.R. Glucocorticoids Regulate Hippocampal 11-beta-Hydroxysteroid Dehydrogenase Activity and Gene Expression In Vivo in the Rat. J. Neuroendocrinol 1994, 6:285-290.
24. Lupien S.J., de Leon M., De Santi S., Convit A., Tarshish C., Thakur M., McEwen B.S., Hauger R.L., Meaney M.J. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat. Neurosci 1998, 1:69-73.
25. MacLullich A.M., Ferguson K.J., Deary I.J., Seckl J.R., Starr J.M., Wardlaw J.M. Intracranial capacity and brain volumes are associated with cognition in healthy elderly men. Neurology 2002, 59:169-174.
26. MacLullich A.M.J., Deary I.J., Starr J.M., Ferguson K.J., Wardlaw J.M., Seckl J.R. Plasma cortisol levels, brain volumes and cognition in healthy elderly men. Psychoneuroendocrinology 2005, 30:505-515.
27. MacLullich A.M.J., Deary I.J., Starr J.M., Walker B.R., Seckl J.R. Glycosylated hemoglobin levels in healthy elderly nondiabetic men are negatively associated with verbal memory. J. Am. Geriatr. Soc 2004, 52:848-849.
28. McEwen B.S. Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol. Aging 2002, 23:921-939.
29. McGurn B., Starr J.M., Topfer J.A., Pattie A., Whiteman M.C., Lemmon H.A., Whalley L.J., Deary I.J. Pronunciation of irregular words is preserved in dementia, validating premorbid IQ estimation. Neurology 2004, 62:1184-1186.
30. Nelson H.E., Willison J.R. NART Test Manual (Part II) 1991, NFER-Nelson, New York.
31. Otte C., Hart S., Neylan T.C., Marmar C.R., Yaffe K., Mohr D.C. A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology 2005, 30:80-91.
32. Patel P.D., Lopez J.F., Lyons D.M., Burke S., Wallace M., Schatzberg A.F. Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J. Psychiatr. Res 2000, 34:383-392.
33. Paterson J.M., Holmes M.C., Kenyon C.J., Carter R., Mullins J.J., Seckl J.R. Liver-selective transgene rescue of hypothalamic-pituitary-adrenal axis dysfunction in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Endocrinology 2007, 148:961-966.
34. Pelletier G., Luu-The V., Li S., Bujold G., Labrie F. Localization and glucocorticoid regulation of 11 beta-hydroxysteroid dehydrogenase type 1 mRNA in the male mouse forebrain. Neuroscience 2007, 145:110-115.
35. Rajan V., Edwards C.R.W., Seckl J.R. Eleven beta-hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J. Neurosci 1996, 16:65-70.
36. Rasmuson S., Andrew R., Nasman B., Seckl J.R., Walker B.R., Olsson T. Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimer's disease. Biol. Psychiatry 2001, 49:547-552.
37. Raven J.C., Court J.H., Raven J. Manual for Raven's Progressive Matrices and Vocabulary Scales 1977, HK Lewis, London.
38. Reig S., Sanchez-Gonzalez J., Arango C., Castro J., Gonzalez-Pinto A., Ortuno F., Crespo-Facorro B., Bargallo N., Desco M. Assessment of the increase in variability when combining volumetric data from different scanners. Hum. Brain Mapp 2009, 30:355-368.
39. Salthouse T.A. Aging and measures of processing speed. Biol. Psych 2000, 54:35-54.
40. Sandeep T.C., Yau J.L.W., MacLullich A.M.J., Noble J., Deary I.J., Walker B.R., Seckl J.R. 11 beta-Hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc. Natl. Acad. Sci. U S A. 2004, 101:6734-6739.
41. Savva G.M., Wharton S.B., Ince P.G., Forster G., Matthews F.E., Brayne C. Age, Neuropathology, and Dementia. N Engl J. Med 2009, 360:2302-2309.
42. Schubert M.I., Kalisch R., Sotiropoulos I., Catania C., Sousa N., Almeida O.F.X., Auer D.P. Effects of altered corticosterold milieu on rat hippocampal neurochemistry and structure - An in vivo magnetic resonance spectroscopy and imaging study. J. Psychiatr. Res 2008, 42:902-912.
43. Sivan A.B. Benton Visual Retention Test 1992, Psychological Corporation, New York. 5th Ed.
44. Starkman M.N., Giordani B., Berent S., Schork M.A., Schteingart D.E. Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosom. Med 2001, 63:985-993.
45. van Rossum E.F.C., de Jong F.J., Koper J.W., Uitterlinden A.G., Prins N.D., van Dijk E.J., Koudstaal P.J., Hofman A., de Jong F.H., Lamberts S.W.J., Breteler M.M.B. Glucocorticoid receptor variant and risk of dementia and white, matter lesions. Neurobiol. Aging 2008, 29:716-723.
46. Walker B.R. Glucocorticoids and cardiovascular disease. Eur. J. Endocrinol 2007, 157:545-559.
47. Wechsler D. Manual of the Wechsler Adult Intelligence Scale - Revised 1981, Psychological Corporation, New York.
48. Wechsler D. Wechsler Memory Scale - Revised (WMS-R) 1987, Psychological Corporation, New York.
49. Yau J.L.W., Mcnair K.M., Noble J., Brownstein D., Hibberd C., Morton N., Mullins J.J., Morris R.G.M., Cobb S., Seckl J.R. Enhanced hippocampal long-term potentiation and spatial learning in aged 11 beta-hydroxysteroid dehydrogenase type 1 knock-out mice. J. Neurosci 2007, 27:10487-10496.
50. Yau J.L.W., Noble J., Kenyon C.J., Hibberd C., Kotelevtsev Y., Mullins J.J., Seckl J.R. Lack of tissue glucocorticoid reactivation in 11 beta-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments. Proc. Natl. Acad. Sci. U S A. 2001, 98:4716-4721.